News
Research brief: Reducing youth interest in flavored vaping products
The popularity of flavored vaping products among young people has been a growing concern in recent years, and a number of campaigns intended to reduce the popularity of these products have been developed as a result. Many of these…
Talking lung cancer awareness with Masonic Cancer Center member Dr. Abbie Begnaud
Did you know that November is National Lung Cancer Awareness Month? According to the Centers for Disease Control and Prevention, lung cancer is the leading cause of cancer death, accounting for 23 percent of all cancer deaths.
Carol Lange, PhD, receives Wall of Scholarship Award
The Wall of Scholarship, located in the Phillips-Wangensteen Building, is a physical representation of the excellent research conducted at the University of Minnesota. The Wall was founded to promote research excellence and helps inspire…
Melissa Geller, MD, MS, to Present Data From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting
-Read the original article by HCW Biologics Inc.-
Digging Deeper Into Breast Cancer Prevention and Screening with Dr. Damé Idossa
Breast cancer is among the top five causes of death in Minnesota Women. Of those, black women have a 40% higher mortality rate than white women when it comes to breast cancer.
New checkpoint gene demonstrates ability to supercharge immune cells against cancer
University of Minnesota researchers and their collaborators at the National Cancer Institute (NCI) investigated the role of a new intracellular checkpoint gene in regulating T-cell function against solid tumors.
Goldy vs. Cancer Day Returns to the Minnesota State Fair
The Masonic Cancer Center announces the return of Goldy vs. Cancer day at the Minnesota State Fair on Friday August 26, 2022 in the University of Minnesota Crossroads Building. It will be Goldy vs. Cancer as we #GOpherACure!
U of M researchers discover protein that may be associated with better prognosis for women with ovarian cancer
Researchers from the University of Minnesota have discovered that a protein associated with metabolism, and formerly recognized as a potential therapeutic target for ovarian cancer, may instead be associated with a better prognosis for…
Minnesota Cancer Clinical Trials Network Announces Development of Collaborative Statewide Educational Campaign
The Minnesota Cancer Clinical Trials Network (MNCCTN) is pleased to announce the development of a statewide educational campaign about clinical trials. The educational campaign aims to increase awareness and understanding of clinical…
Research from the University of Minnesota Influences FDA Decision to Move Towards Lowering Nicotine Levels in Cigarettes
A decades-long collaborative research effort that determined that a lower dose of nicotine in cigarettes led to a reduction in cigarette smoking, exposure to carcinogens and dependence, and an increase in attempts to quit has finally paid…